New treatments for myasthenia: a focus on antisense oligonucleotides

Autoimmune myasthenia gravis (MG) is a neuromuscular disorder caused by autoantibodies directed against the acetylcholine receptor (AChR). Current symptomatic therapy is based on acetylcholinesterase (AChE) drugs. The available long-term current therapy includes steroids and other immunomodulatory a...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelini, Corrado, Martignago, Sara, Bisciglia, Michela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546757/
https://www.ncbi.nlm.nih.gov/pubmed/23341732
http://dx.doi.org/10.2147/DDDT.S25716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546757/
https://www.ncbi.nlm.nih.gov/pubmed/23341732
http://dx.doi.org/10.2147/DDDT.S25716

Ejemplares similares